SCLC is the most common type of lung neuroendocrine tumor. Not all cases of SCLC have neuroendocrine markers. About 5% to 10% of SCLC tumors are neuroendocrine-negative. But these tumors still ...

This article examines SCLC and other neuroendocrine tumors ... For example, when a tumor starts growing in the lungs, doctors refer to it as a lung NET. These tumors may not cause noticeable ...

Small cell lung cancer (SCLC ... and becoming non-neuroendocrine (non-NE) cancer cells. They also observed that together, these cancer cells collaborated to promote tumor development.

4 SCLC is classified as a neuroendocrine tumor by the World Health Organization, and is categorized based on its characteristic histology and lack of expression of neuroendocrine phenotype markers ...

It is possible that Harpoon might get the green light from the FDA to initiate one or more phase 2/3 studies, using HPN328 to treat patients with SCLC and other neuroendocrine tumor types.

“At just 40% of the administered dose reported for Ac-DOTATATE, Ac-EBTATE produces enhanced anti-tumor efficacy in small cell lung cancer (SCLC) and Pan-neuroendocrine tumor (NET) models as ...

PLLP may relate to SCLC's neuroendocrine features ... immune response, and tumor progression, though more research is needed. According to the authors, this new research offers hope for more ...

NSCLC is a less aggressive and more common form of lung cancer than SCLC. Your doctor will know which type of lung cancer you have when they take a biopsy, or small sample of the tumor ...

In SCLC, the confirmed response rate was 32% (6/19) with one confirmed complete response. In patients with other neuroendocrine tumor types, such as prostate cancer, small cell cervical ...